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Abstract
Background: Dietary strategies that help patients adhere to a weight reduction diet may increase the likelihood of
weight loss maintenance and improved long-term health outcomes. Regular nut consumption has been associated
with better weight management and less adiposity. The objective of this study was to compare the effects of a
walnut-enriched reduced-energy diet to a standard reduced-energy-density diet on weight, cardiovascular disease
risk factors, and satiety.
Methods: Overweight and obese men and women (n = 100) were randomly assigned to a standard reduced-
energy-density diet or a walnut-enriched (15% of energy) reduced-energy diet in the context of a behavioral
weight loss intervention. Measurements were obtained at baseline and 3- and 6-month clinic visits.
Participants rated hunger, fullness and anticipated prospective consumption at 3 time points during the intervention.
Body measurements, blood pressure, physical activity, lipids, tocopherols and fatty acids were analyzed using repeated
measures mixed models.
Results: Both study groups reduced body weight, body mass index and waist circumference (time effect p < 0.001 for
each). Change in weight was −9.4 (0.9)% vs. -8.9 (0.7)% (mean [SE]), for the standard vs. walnut-enriched diet groups,
respectively. Systolic blood pressure decreased in both groups at 3 months, but only the walnut-enriched diet group
maintained a lower systolic blood pressure at 6 months. The walnut-enriched diet group, but not the standard
reduced-energy-density diet group, reduced total cholesterol and low-density lipoprotein cholesterol (LDL-C) at
6 months, from 203 to 194 mg/dL and 121 to 112 mg/dL, respectively (p < 0.05). Self-reported satiety was similar
in the groups.
Conclusions: These findings provide further evidence that a walnut-enriched reduced-energy diet can promote
weight loss that is comparable to a standard reduced-energy-density diet in the context of a behavioral weight
loss intervention. Although weight loss in response to both dietary strategies was associated with improvements
in cardiovascular disease risk factors, the walnut-enriched diet promoted more favorable effects on LDL-C and
systolic blood pressure.
Trial registration: The trial is registered at (NCT02501889).
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Introduction
Current guidelines for the management of overweight
and obesity recommend prescribing a reduced-energy
diet as a primary treatment intervention to promote
weight loss, as part of a comprehensive lifestyle inter-
vention, and conclude that a variety of dietary ap-
proaches can produce weight loss [1]. However,
dietary patterns, specific foods, and macronutrient
composition may differentially affect metabolic
factors, satiety, and the postprandial gastrointestinal
peptide response that could affect hunger and appe-
tite [2, 3]. Dietary strategies that help patients reduce
energy intake and adhere to a reduced-energy diet
may increase the likelihood of improved long-term
health outcomes and reduced risk for obesity-related
conditions and diseases.
In several large cohorts and a few clinical trials, a
dietary pattern that includes regular nut consumption
has been associated with less weight gain in adulthood
and a lower degree of adiposity [4–11]. In a few previous
studies, the effects of consuming almonds, pistachios,
walnuts and peanuts on weight change and cardiovascu-
lar disease risk factors in the context of a weight loss
intervention have been examined, with mixed results
[12–18]. A proposed mechanism for the favorable effect
of nuts on weight control is that they promote increased
satiety, resulting in a compensatory reduction in total
energy intake [4, 5]. Feelings of satiety, fullness, and
hunger following walnut consumption has been exam-
ined in only a few previous studies. In those studies,
acute postprandial peptide response and early phase sati-
ety was observed to be similar following a meal with or
without walnuts, although increased satiety and fullness
were found on days 3 and 4 following a walnut-
containing meal [19, 20]. Measuring responses over the
long-term would better model the observational studies
that have linked regular nut consumption with lower
adiposity and better weight control.
In the present study, we compared the effects of a
walnut-enriched reduced-energy diet to a reduced-
energy-density diet, which has been suggested to be a
useful dietary strategy to promote reduced energy intake
without compromising meal satiety [21]. The primary
objective of this study was to compare the effects of a
walnut-enriched reduced-energy diet to a standard
reduced-energy-density diet on body weight and cardio-
vascular disease risk factors in a sample of overweight
and obese adults in an intensive 6-month weight loss
intervention. A secondary objective was to examine
whether there is a differential response in satiety- and
appetite-related ratings scales in association with a
walnut-enriched reduced-energy diet and a reduced-
energy-density diet among the participants in this
weight-loss study.
Methods
Subjects
One hundred non-diabetic overweight and obese men
and women were randomized from a screened sample of
647 (Fig. 1). To be included in the study, participants
had to meet the following criteria: Aged 21 years and
older, body mass index (BMI) between 27 and 40 kg/m2;
willing and able to participate in clinic visits, group ses-
sions, and telephone and internet communications; able
to provide data through questionnaires and telephone;
willing to maintain contact with investigators for
Fig. 1 Flow chart for study participants
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6 months; willing to allow blood collections; no known
allergy to tree nuts; and capable of performing a simple
test for assessing cardiopulmonary fitness. Exclusion
criteria were any of the following: Inability to participate
in physical activity due to severe disability; history or
presence of a comorbid diseases where diet modification
and increased physical activity may be contraindicated;
self-reported pregnancy or breastfeeding or planning a
pregnancy within the next year; currently involved in
another diet intervention study or weight loss program;
and having a history or presence of a significant psychi-
atric disorder or any condition that would interfere with
participation in the trial. The University of California,
San Diego (UCSD), institutional review board approved
the study protocol, and all participants provided written
informed consent.
Prior to enrollment, potential participants were screened
for diabetes and considered ineligible with a fasting blood
glucose ≥125 mg/dL. At screening and recruitment, the
ability to participate in moderate intensity physical activity
was assessed by questionnaire, a standard procedure for
screening participants for community-based weight loss
programs of this nature. Participants were additionally
asked to report all prescription medications and were
asked if they had ever been told by a doctor that they had
high blood cholesterol. Once enrolled, participants were
randomly assigned to one of the two study arms using a
sequence stratified by age (≤52 vs. >52 years) and BMI
(≤33 vs. >33 kg/m2).
Intervention
All participants were provided a detailed diet prescrip-
tion in an individual counseling session with a dietitian,
in which a caloric deficit was set based on the partici-
pant’s goals, and a sample meal plan was developed
according to study arm and participant food preferences.
The overall goal of the dietary guidance was to promote
a reduction in energy intake, aiming for a 500- to 1000-
kcal/day deficit relative to expenditure. All participants
had follow-up contact with the dietitian by telephone or
email a minimum of every 1–2 weeks for additional
support and to reinforce adherence throughout the
intervention.
Participants assigned to the standard reduced-energy-
density diet arm were provided diet plans that empha-
sized lower energy density food choices such as vegeta-
bles, fruit and whole grains, as well as lean protein
sources and reduced-fat dairy foods, with macronutrient
composition within current guidelines (https://
www.choosemyplate.gov/MyPlate). Participants assigned
to this study group were asked to refrain from eating
any nuts (and products containing them) for the dur-
ation of the study.
Participants assigned to the walnut-enriched reduced-
energy study group were instructed to consume an aver-
age of 42 g (1.5 oz) of walnuts/day for diet prescriptions
that were ≥1500 kcal/day, or 28 g (1 oz) of walnuts/ for
diet prescriptions <1500 kcal/day, all within their
energy-reduced diet plan (thus, walnuts provided ap-
proximately 15% of total energy intake). Participants
were provided meal and snack suggestions and recipes
to facilitate adherence, and the nuts were distributed to
participants assigned to that group on a weekly basis for
12 weeks and then biweekly for the remainder of the
study. Also, participants were queried about walnut con-
sumption for the previous week when the walnuts were
distributed, and adherence was recorded.
Use of a Web-based planning and tracking program
that enabled tracking kilocalories was encouraged. All
participants were provided a scale and were asked to
weigh themselves daily and to record their progress. An
activity tracker was provided and participants were
asked to gradually build up to a minimum of 10,000
steps per day within the first month and then to main-
tain or increase that level of lifestyle activity. An add-
itional daily exercise goal was an average of at least
60 min/day of purposeful aerobic activity at a moderate
level of intensity. Strength training 2–3 times/week also
was encouraged. Tools such as measuring cups, small
exercise equipment, and videos were provided to en-
courage adherence.
In addition to individualized diet prescription and
counseling, all participants were assigned to a series of
closed group sessions (weekly for 12 weeks, then bi-
weekly), based on a semi-structured cognitive-behavioral
weight loss intervention. Briefly, strategies discussed in-
cluded: Planning and tracking meals and exercise; envir-
onmental control; realistic goal-setting; triggers to eating
and ways to deal with them; problem-solving; dealing
with negative thoughts; promoting self-efficacy through
goal accomplishments and other strategies; self-
nurturing; dealing with lapses; and addressing body
image concerns.
Measurements
Study data were collected and managed using a Research
Electronic Data Capture (REDcap) database hosted at
UCSD [22]. At baseline and 3- and 6-month follow-up
data collection clinic visits, weight, height (baseline
only), waist circumference, and blood pressure were
measured, and a fasting (≥6 h) blood sample and ques-
tionnaires were collected. Systolic and diastolic blood
pressure was averaged from two sitting blood pressure
measurements. The 3-min step test, which measures
heart rate during the first 30 s of recovery from stepping,
was used to assess cardiopulmonary fitness. This test has
high reliability and is sensitive to change [23].
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Physical activity was estimated using the Godin
Leisure-Time Exercise Questionnaire, a validated self-
report measure of physical activity that has been widely
used in previous research [24]. This questionnaire as-
sesses weekly hours of moderate and strenuous physical
activity. These data were compared with current recom-
mendations for physical activity in adults, which are
150 min weekly of moderate physical activity, or 75 min
weekly of strenuous physical activity, or a combination
of these [25].
Participants were asked to rate general (rather than
meal-specific) satiation by using a visual analog scale
(VAS), an approach which has been shown to have valid-
ity, reliability, and reproducibility [26]. Similar to other
studies in which satiety and satiation over time (rather
than meal-specific) have been assessed [19], participants
were asked to complete these scales before lunch and
dinner meals at three time points during the 6 months
of active participation (weeks 1, 6, and 13). Specifically,
subjects were asked to rate their satiety by answering
three questions. Each of the questions was completed by
the participant and transferred by staff (blinded to study
arm assignment) to a REDCap (Vanderbilt University,
Nashville, TN, USA) file database, with a 100 mm hori-
zontal line anchored at either end, so that answers can
be quantified on a continuous scale. The questions are:
“How hungry do you feel?” with anchor values ranging
from “I have never been more hungry” (scored as 0) to
“I am not hungry at all” (scored as 100); “How full do
you feel?”, with anchor values ranging from “Not at all
full” (scored as 0) to “Totally full” (scored as 100); and
“How much do you think you could eat now?” with an-
chor values ranging from “Nothing at all” (scored as 0)
to “A lot” (scored as 100).
Laboratory measures
Laboratory measurements were conducted with plasma
samples that had been frozen at -80οC after blood collec-
tion and processing. Total cholesterol, triglycerides, and
high-density lipoprotein cholesterol (HDL-C) were mea-
sured by Arup Laboratories (Salt Lake City, UT, USA)
using enzymatic methods. The coefficient of variation
(CV) for human serum for cholesterol at 76.2 mg/dL
and 276 mg/dL is 1.6% and 1.4%, respectively; for tri-
glycerides at 104 mg/dL and 261 mg/dL is 1.9% and
1.8%, respectively; and for HDL-C at 46.4 mg/dL and
80.4 mg/dL is 0.6% and 0.7%, respectively. Low-density
lipoprotein cholesterol (LDL-C) values were calculated
by the Friedewald equation [27].
Tocopherols and fatty acids were measured as dietary
biomarkers because we anticipated that the walnut-
enriched diet group could have different circulating con-
centrations compared to participants in the standard diet
arm, reflecting differential intake of these dietary
constituents due to regular walnut consumption. The
detection and quantification of plasma tocopherols was
accomplished by high performance liquid chromatog-
raphy, using fluorescent detection at a wavelength of
295 nm excitation and 325 nm emission. Tocopherols
were quantified by peak height using a standard curve
prepared in bovine serum matrix from pure external
compounds. Additionally, pooled in-house quality con-
trol samples were analyzed concurrently with batches of
study samples, together with other commercially avail-
able reference samples, to monitor accuracy and preci-
sion. Also, the laboratory participates in the National
Institute of Standards and Technology quality assurance
program.
Red blood cell (RBC) fatty acids were measured by
OmegaQuant Laboratories (Sioux Falls, SD, USA) by gas
chromatography (GC) with flame ionization detection.
GC was carried out using a GC2010 Gas Chromato-
graph (Shimadzu Corporation, Columbia, MD, USA)
equipped with a SP2560, 100-m fused silica capillary col-
umn (0.25 mm internal diameter, 0.2 um film thickness;
Supelco, Bellefonte, PA, USA). Fatty acids were identified
by comparison with a standard mixture of fatty acids
characteristic of RBCs (GLC OQ-A, NuCheck Prep,
Elysian, MN, USA) which was also used to determine in-
dividual fatty acid calibration curves. Fatty acid compos-
ition was expressed as a percent of total identified fatty
acids.
Statistical analysis
Demographic characteristics were compared at baseline
between groups using chi-square tests for categorical
variables and t-tests for continuous variables. Body mea-
surements (weight, BMI, waist circumference), blood
pressure, physical activity, lipids, tocopherols and fatty
acids were analyzed using repeated measures mixed
models assuming unstructured covariance. Change in an
indicator of adiposity between groups (weight change as
a percentage of initial weight) was also analyzed. Study
time, diet group, and the group by time interaction were
modeled as fixed effects in each model. Variables that
were skewed were log transformed in analysis.
Lipid concentrations were examined by sex to assess
significant differences at baseline. We tested to see
which of the lipids changed between baseline and
6 months, and if a significant change was observed, we
performed multivariate analysis to identify predictors of
such a lipid change.
Power analysis for our sample size was based on pub-
lished literature for nut consumption in a weight loss
intervention [15–17]. Significance was set at alpha =
0.05. All statistical analysis was performed using the SAS
software version 9.4 for Windows (SAS Institute Inc.,
Cary, North Carolina, USA).
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Results
During the course of the study, 3 participants dropped
out (one in the standard diet group and 2 in the walnut-
enriched diet group). Overall compliance with prescribed
walnut consumption in that study arm was 98%; review
of monitoring records indicated that of the 47 partici-
pants, 43 reported consuming 97–100%, 2 reported con-
suming 92–96%, and 2 reported consuming 67–69% of
the walnuts prescribed during the study.
As shown in Table 1, the randomized study groups did
not differ by sex, age, education, or race/ethnicity. Both
groups demonstrated a reduction in body weight, BMI,
and waist circumference (time effect p < 0.001 for each)
during the course of the study, and the two diet groups
did not differ in degree of weight lost, with no significant
group by time interactions, as shown in Table 2. Both
groups decreased their systolic blood pressure at
3 months, but only those in the walnut-enriched diet
group maintained a lower systolic blood pressure at
6 months compared to baseline (Table 3). Participants in
both study groups also decreased their diastolic blood
pressure at 3 and 6 months, and increased their physical
activity (p < 0.001 for each). There was no significant
group by time interaction observed in the blood pressure
or physical activity models (Table 3). Cardiopulmonary
fitness, as indicated by the step test recovery heart rate,
improved in both study groups.
Participants assigned to the walnut-enriched diet
group, but not the standard reduced-energy-density diet
group, had a reduction in total cholesterol concentration
at 6 months, from 203 to 194 mg/dL (p = 0.04), as
shown in Table 4. Triglycerides decreased in the
standard diet group at 3 months and in both groups at
6 months, which decreased an average of 22 mg/dL from
128 to 106 (p < 0.01 in log-transformed analysis). HDL-
C did not change significantly between baseline and
6 months in either of the diet groups. In a subgroup
analysis among the 21 men in the study, those assigned
to the walnut-rich diet group had lower HDL-C levels
(42 [10] vs. 50 [7] mg/dL [mean (SD)]) than those
assigned to the standard reduced-energy-density diet at
baseline (p = 0.05) and at 3 months, 41(9) vs 54 (13) mg/
dL (p = 0.02) (data not shown). By 6 months, the men
assigned to the walnut-enriched diet group had in-
creased their HDL-C to 49 (18) mg/dL, and those in the
standard reduced-energy-density diet group had also
increased HDL-C to 59 (13) mg/dL (data not shown).
Although 27% of the cohort reported having been told
by a doctor that they had high cholesterol, only 10% of
the cohort reported taking prescription medications to
lower lipids.
The overall change (in both groups combined) in
total cholesterol at 6 months was −7 mg/dL and for
triglycerides was −20 mg/dL. A multivariate model
for change in triglycerides did not show that diet
group assignment, weight loss, age, sex, or level of
physical activity were significantly associated; however,
a model for change in total cholesterol showed that
weight change and age were significantly associated.
In the multivariate model for change in cholesterol at
6 months, R-squared was 0.17 and the two factors
significantly associated were age (p = 0.002) and
weight change (p = 0.02). Diet, baseline BMI, baseline
physical activity, and change in physical activity were
not significantly related to cholesterol change. Partici-
pants >50 years of age decreased their cholesterol by
2 mg/dL compared with a decrease of 19 mg/dL for
subjects younger than 50 years of age. Those who lost
≥5% of initial weight decreased their cholesterol by
an average of 13 mg/dL compared with an increase in
cholesterol of 18 mg/dL in subjects who did not lose
at least 5% of initial body weight.
As shown in Table 4, we did not observe changes in
alpha- or gamma-tocopherol, which are the major to-
copherols in the plasma, and only minor changes in
beta- and delta-tocopherol concentrations. Also, we
observed increased concentrations of alpha-linolenic
acid and linoleic acid in the walnut-enriched diet group
over the study period, but not in the standard reduced-
energy-density diet group (Table 4).
Self-reported satiety was similar across the study in
the diet groups (Table 5). Feelings of hunger decreased
and fullness was greater at week 12 than week 1 in the
standard reduced-energy-density diet group (p < 0.05).
Fullness was lower in the walnut-rich diet arm at week
12 (p = 0.04).
Table 1 Characteristics of study participants in the weight
reduction intervention
Standard
reduced-
energy-density
diet
(n = 51)
Walnut-enriched
reduced-energy
diet
(n = 49)
p
(between
groups) *
Sex (N [%]) 0.53
Female 27 (53%) 31 (63%)
Male 24 (47%) 18 (37%)
Age (years), mean (SE) 52.2 (1.6) 53.3 (1.4) 0.63
Education (years),
mean (SE)
16.1 (0.3) 16.2 (0.3) 0.88
Race/ethnicity (%) 0.84
Non-Hispanic white 73 73
Hispanic/Latino 14 18
African-American 6 2
Asian-American 2 2
Mixed/other 6 4
*p values are from chi-square tests (categorical variables), or t-tests
(continuous variables)
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Table 3 Blood pressure and physical activity variables for study participants in the weight reduction intervention
Standard reduced-energy-density diet Walnut-enriched reduced-energy diet p (between groups)
n Mean(SE) n Mean(SE)
Systolic blood pressure, mm Hg
Baseline 51 123 (2) 49 124 (3) 0.77
3 Months 49 117 (2) * 48 116 (2) * 0.73
6 Months 49 119 (2) 46 118 (2) * 0.68
Diastolic blood pressure, mm Hg
Baseline 51 82 (1) 49 82 (2) 0.72
3 Months 49 77 (1) * 48 76 (1) * 0.57
6 Months 49 78 (2) * 46 77 (1) * 0.70
Moderate/strenuous physical activity, minutes/week
Baseline 51 120 (22) 49 133 (18) 0.53
3 Months 51 328 (31) * 48 337 (33) * 0.84
6 Months 49 351 (31) * 47 321 (29) * 0.48
% Meeting physical activity recommendations
Baseline 51 25 49 45 0.04
3 Months 51 78 48 79 0.93
6 Months 47 85 47 81 0.58
Step test, heart rate/30s
Baseline 51 57 (2) 49 60 (2) 0.14
3 Months 47 47 (1) * 47 49 (1) * 0.33
6 Months 47 45 (1)* 45 47 (1) * 0.18
* Different from baseline within group, p < 0.01 for each
Table 2 Body measurements of study participants in the weight reduction intervention
Standard reduced- energy-density diet Walnut-enriched reduced-energy diet p (between groups)
n Mean (SE) n Mean (SE)
Body weight, kg a
Baseline 51 90.9 (1.8) 49 91.1 (2.3) 0.96
3 Months 51 84.7 (1.8) 48 85.9 (2.3) 0.70
6 Months 50 82.1 (2.0) 47 82.4 (2.2) 0.92
Body mass index, kg/m2 a
Baseline 51 32.4 (0.4) 49 32.4 (0.5) 0.96
3 Months 51 30.3 (0.5) 48 30.6 (0.5) 0.63
6 Months 50 29.4 (0.6) 47 29.6 (0.5) 0.77
Weight change, kg
3 Months 51 −6.0 (0.6) 48 −5.5 (0.5) 0.51
6 Months 50 −8.5 (0.9) 47 −7.9 (0.6) 0.58
% Weight change
3 Months 51 −6.6 (0.6) 48 −6.1 (0.6) 0.53
6 Months 50 −9.4 (0.9) 47 −8.9 (0.7) 0.63
Waist circumference, cm a
Baseline 51 109.9 (1.2) 49 111.5 (1.6) 0.42
3 Months 51 101.7 (1.3) 48 104.6 (1.6) 0.16
6 Months 50 98.9 (1.4) 47 100.7 (1.5) 0.39
a Body weight, body mass index, and waist circumference showed a significant time effect compared with baseline, p < 0.001 for each variable, in both
study groups at each follow-up point
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Table 4 Biological measures of study participants in the weight reduction intervention
Standard reduced-energy-density diet Walnut-enriched reduced-energy diet p (between groups) p (group x time interaction)
Mean(SE) Mean(SE)
Cholesterol, mg/dL 0.84
Baseline 200 (5) 203 (6) 0.76
3 Months 199 (5) 198 (5) 0.95
6 Months 194 (6) 194 (6) a 0.91
Triglycerides, mg/dL 0.50
Baseline 130 (10) 123 (7) 0.55
3 Months 110 (8) a 115 (9) 0.66
6 Months 109 (9) a 103 (6) a 0.61
HDL cholesterol, mg/dL 0.08
Baseline 58 (2) 59 (2) 0.70
3 Months 60 (2) 58 (2) 0.37
6 Months 60 (2) 61 (2) 0.94
LDL Cholesterol, mg/dL 0.60
Baseline 116 (4) 121 (5) 0.42
3 Months 116 (5) 116 (4) 0.80
6 Months 112 (5) 112 (5) a 0.96
Alpha-tocopherol, μmol/L 0.96
Baseline 30.5 (1.3) 30.8 (1.0) 0.83
3 Months 30.0 (1.1) 30.3 (1.2) 0.72
6 Months 31.6 (1.2) 32.2 (1.3) 0.84
Beta-tocopherol, μmol/L 0.70
Baseline 0.33 (0.02) 0.33 (0.01) 0.38
3 Months 0.38 (0.01) a 0.27 (0.01) a 0.38
6 Months 0.28 (0.01) a 0.26 (0.01) a 0.99
Gamma-tocopherol, μmol/L 0.48
Baseline 4.23 (0.29) 3.99 (0.27) 0.55
3 Months 4.04 (0.31) 4.13 (0.20) 0.82
6 Months 4.08 (0.33) 4.30 (0.29) 0.74
Delta-tocopherol, μmol/L 0.98
Baseline 0.11 (0.01) 0.11 (0.01) 0.82
3 Months 0.10 (0.01) 0.10 (0.01) 0.88
6 Months 0.09 (0.01) a 0.08 (0.01) a 0.76
Linoleic acid, % <0.001
Baseline 0.111 (0.002) 0.110 (0.002) 0.77
3 Months 0.104 (0.002) a 0.111 (0.002) 0.004
6 Months 0.107 (0.002) a 0.112 (0.001) a 0.01
Alpha-linolenic acid, % <0.001
Baseline 0.00122 (0.00006) 0.00118 (0.00004) 0.57
3 Months 0.00105 (0.00006) a 0.00147 (0.00005) a <0.001
6 Months 0.00118 (0.00005) 0.00158 (0.00007) a <0.001
a Different from baseline within group, p < 0.05
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Discussion
Findings from this study provide further evidence that a
walnut-enriched reduced-energy diet can promote
weight loss that is comparable to a standard reduced-
energy-density diet in the context of a behavioral weight
loss intervention. Although weight loss in response to
both dietary strategies was associated with improve-
ments in lipids and blood pressure, the walnut-enriched
diet promoted more favorable effects on some cardiovas-
cular disease risk factors, such as LDL-C and systolic
blood pressure.
Previous studies that have examined the effect of pre-
scribing regular nut consumption on weight change in a
weight loss intervention have had mixed results. Two stud-
ies found more weight loss in association with almond con-
sumption (at doses of 50–84 g/day for 3 months)
compared with controls [12, 16], while a study examining
the effect of a similar amount of almonds over a longer
time frame (18 months) did not observe more weight loss
compared to controls [15]. In a study that examined the
effects of prescribing peanuts (16% of energy), weight loss
was similar to controls, although the peanut-containing
study arm had more favorable effects on cardiovascular dis-
ease risk factors [13]. Providing a daily snack of pistachios
(53 g/day) vs. pretzels promoted a greater reduction of BMI
and plasma triglyceride concentration but only a trend for
a difference in body weight change in another study [14]. In
a 12-month intervention study aimed to promote weight
loss and healthy lifestyle, prescribing 30 g/day walnuts was
associated with greater weight loss and improved diet qual-
ity compared to providing general dietary advice during the
3-month intensive phase of the intervention, although these
differences were not evident at study end [17].
We recently examined the effects of a walnut-rich or
higher-monounsaturated fat diet vs. a lower-fat diet pre-
scription on weight loss and selected lipids and bio-
markers in the context of a 12-month behavioral weight
loss program [18, 28]. Participants were stratified by
insulin resistance status to allow examination of whether
insulin resistance might be associated with differential
response to diet composition. Similar to the present
study, we observed that prescribing walnuts was associ-
ated with weight loss that was comparable to a standard
lower fat diet, but better than a higher fat, lower carbo-
hydrate diet without walnuts with regard to biomarker
response [18].
In addition to promoting a similar degree of weight
loss, we observed similar self-reported satiety in re-
sponse to a walnut-enriched reduced-energy diet and a
reduced-energy-density diet, that has been proposed to
promote reduced energy intake without compromising
meal satiety [21]. Notably, walnuts are very high in en-
ergy density, but when consumed as a component of a
reduced-energy diet, this strategy may help to promote
adherence to restricted total energy intake.
The effects of tree nuts on blood lipids and several
other cardiovascular disease risk factors were recently
examined in a systematic review and meta-analysis [29],
as well as in an earlier pooled analysis [30], and our
observations of lower cholesterol and LDL-C in response
to walnut consumption are in agreement with their con-
clusions. Across the 61 trials that met the eligibility
criteria for the meta-analysis, that study found an aver-
age reduction of −4.7 and −4.8 mg/dL for total choles-
terol and LDL-C, respectively, per one ounce/day
serving of tree nuts in interventions ranging from 3 to
Table 5 Self-reported satiety (on a 100-point visual analog scale where Hunger is scored 0 = very hungry, 100 = not hungry at all;
Fullness is scored 0 = not full, 100 = full; Quantity is scored 0 = nothing, 100 = a lot) in the weight reduction intervention
Standard reduced-energy-density diet, mean(SEM) Walnut-enriched reduced-energy diet, mean(SEM)
Lunch Dinner Lunch Dinner
Hunger
Week 1 43 (3) 40 (4) 49 (3) 40 (3)
Week 6 50 (4) 43 (4) 42 (4) 45 (4)
Week 12 53 (5) a 49 (4) a 44 (4) 44 (4)
Fullness
Week 1 44(4) 48 (5) 51(4) 51(5)
Week 6 53 (5) 53 (42) 58 (4) 52 (5)
Week 12 52 (6) a 61 (5) a 48 (4) b 49 (4) b
Quantity
Week 1 44(4) 50 (4) 49 (3) 55(4)
Week 6 49 (4) 53 (4) 48 (4) 47 (4)
Week 12 41 (4) 38 (5) 44 (3) 49 (4)
a Both hunger and fullness were greater at week 12 than week 1 in the standard reduced-energy-density diet group (p < 0.05)
b At week 12, fullness was lower in the walnut-rich diet arm than in the standard reduced-energy-density diet group (p = 0.04)
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26 weeks [29]. Results of the present study, in which we
observed this walnut-specific effect to be even greater in
the context of a weight loss intervention, add to the evi-
dence base. We also observed the effect to be modulated
by age and degree of weight loss, with a greater reduc-
tion in cholesterol in younger individuals (<50 years)
and those with greater weight loss (≥5% of initial
weight). Previous meta-analyses of the effects of nut
consumption on blood pressure are not in agreement,
with one of them concluding that there are no signifi-
cant effects [29] and another showing a reduction in sys-
tolic blood pressure in participants without type 2
diabetes [31] as observed in the present study.
Walnuts are rich in gamma-tocopherol and polyunsat-
urated fatty acids, particularly alpha-linolenic and linoleic
fatty acids [32]. In previous studies, an increase in
gamma-tocopherol concentration has been observed in
participants who were prescribed daily walnut consump-
tion [33, 34]. In our previous trial that prescribed walnuts
in a weight loss intervention [18, 35], we observed that
walnut prescription minimized the reduction in plasma
gamma-tocopherol that occurs in association with
reduced energy intake and weight loss, as was observed in
the present study. The increase in RBC alpha-linolenic
and linoleic fatty acid concentrations in those assigned to
the walnut-enriched reduced-energy study arm, and the
differences across diet groups, is consistent with previous
walnut feeding and walnut-rich diet interventions [18, 33,
36]. These changes in dietary biomarkers also provide
strong support for the self-reported high level of adher-
ence in participants instructed to consume walnuts daily
in the present study. Notably, replacing saturated fats with
polyunsaturated fats has been consistently associated with
reduced risk for cardiovascular disease [37, 38].
This study has some strengths and limitations. A
strength is the heterogeneity of the study sample,
which included both men and women and partici-
pants across racial/ethnic groups. Also, the retention
rate was very high, which is not typical of weight loss
intervention studies, and this reduces ambiguity in
drawing inferences from this study. A limitation of
the study is the lack of detailed information about
dietary intake. We encouraged study participants to
self-monitor dietary intake as a component of the be-
havioral strategies to promote weight control, but we
did not collect detailed dietary data in an effort to
minimize subject burden. Because this was a sample
of free-living individuals, some variability in adher-
ence to the prescribed diet is likely. However, the
weight loss demonstrated by study participants sug-
gests that most were consuming a reduced-energy
diet, and the RBC fatty acid biomarker is indicative of
good compliance by participants in the walnut-
enriched diet group.
Conclusions
In conclusion, findings from this study provide further
evidence that a walnut-enriched reduced-energy diet can
promote weight loss that is comparable to a standard
reduced-energy-density diet in the context of a behav-
ioral weight loss intervention. Weight loss in response to
both of these dietary strategies was associated with im-
provements in lipids and blood pressure, although the
walnut-enriched diet promoted more favorable effects
on LDL-C and systolic blood pressure.
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